Oncotarget

Research Papers:

MiRNA203 suppresses the expression of protumorigenic STAT1 in glioblastoma to inhibit tumorigenesis

Chuan He Yang _, Yinan Wang, Michelle Sims, Chun Cai, Ping He, Junming Yue, Jinjun Cheng, Frederick A. Boop, Susan R. Pfeffer and Lawrence M. Pfeffer

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:84017-84029. https://doi.org/10.18632/oncotarget.12401

Metrics: PDF 1414 views  |   HTML 1810 views  |   ?  


Abstract

Chuan He Yang1,2, Yinan Wang1,2, Michelle Sims1,2, Chun Cai2,3, Ping He2,4, Junming Yue1,2, Jinjun Cheng1, Frederick A. Boop3, Susan R. Pfeffer1,2 and Lawrence M. Pfeffer1,2

1 Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, Tennessee

2 Center for Cancer Research, University of Tennessee Health Science Center, Memphis, Tennessee, USA

3 Department of Neurosurgery, University of Tennessee Health Science Center, Memphis, Tennessee, USA

4 Department of Nephrology, Shengjing Hospital of China Medical University, Shenyang, China

Correspondence to:

Lawrence M. Pfeffer, email:

Keywords: miR203; glioblastoma; tumorigenesis; apoptosis; STAT1

Received: September 22, 2016 Accepted: September 26, 2016 Published: October 02, 2016

Abstract

MicroRNAs (miRNAs) play critical roles in regulating cancer cell proliferation, migration, survival and sensitivity to chemotherapy. The potential application of using miRNAs for cancer prognosis holds great promise but miRNAs with predictive value remain to be identified and underlying mechanisms of how they promote or suppress tumorigenesis are not completely understood. Here, we show a strong correlation between miR203 expression and brain cancer patient survival. Low miR203 expression is found in subsets of brain cancer patients, especially glioblastoma. Ectopic miR203 expression in glioblastoma cell lines inhibited cell proliferation and migration, increased sensitivity to apoptosis induced by interferon or temozolomide in vitro, and inhibited tumorigenesis in vivo. We further show that STAT1 is a direct functional target of miR203, and miR203 level is negatively correlated with STAT1 expression in brain cancer patients. Knockdown of STAT1 expression mimicked the effect of overexpression of miR203 in glioblastoma cell lines, and inhibited cell proliferation and migration, increased sensitivity to apoptosis induced by IFN or temozolomide in vitro, and inhibited glioblastoma tumorigenesis in vivo. High STAT1 expression significantly correlated with poor survival in brain cancer patients. Mechanistically, we found that enforced miR203 expression in glioblastoma suppressed STAT1 expression directly, as well as that of a number of STAT1 regulated genes. Taken together, our data suggest that miR203 acts as a tumor suppressor in glioblastoma by suppressing the pro-tumorigenic action of STAT1. MiR203 may serve as a predictive biomarker and potential therapeutic target in subsets of cancer patients with low miR203 expression.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 12401